We assisted a biopharmaceutical manufacturer with a limited distribution network oncology drug launch. The distribution strategy included third-party logistics providers, specialty drug distributors and specialty pharmacies. The manufacturer offered patient services through its network specialty pharmacies and hub. Bass, Berry & Sims provided holistic regulatory and contracting support for the launch which included, structuring the distribution and services strategy; guidance on the third party logistic provider and specialty distributor contracts; guidance related to the core and enhanced specialty pharmacy services required of network specialty pharmacies and the hub, such as patient adherence, quick start programs, bridge programs and data services; and drafting and assisting with the negotiation of the specialty pharmacy drug purchase agreements and services agreements.